血压传感器市场（2026—2031）
血压传感器市场规模预计由2026年的19亿美元增至2031年的25.6亿美元，预测期复合年增长率为6.12%。北美是当前最大市场，亚太地区增长最快。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
血压传感器市场规模预计由2026年的19亿美元增至2031年的25.6亿美元，预测期复合年增长率为6.12%。北美是当前最大市场，亚太地区增长最快。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 6.12% | 机构预测 |
| 市场规模 | 2026 | USD 1.9 billion | 机构预测 |
| 市场规模 | 2031 | USD 2.56 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| end-user | hospitals and clinics | 2025 | 43.260% |
| geography | North America | 2025 | 46.610% |
| procedure | invasive monitoring | 2025 | 52.370% |
| product_type | reusable devices | 2025 | 53.140% |
| technology | digital transducers | 2025 | 40.250% |
关键结论
- end-user 维度中，hospitals and clinics 在 2025 年的公开份额为 43.26%。
- geography 维度中，North America 在 2025 年的公开份额为 46.61%。
- procedure 维度中，invasive monitoring 在 2025 年的公开份额为 52.37%。
- product_type 维度中，reusable devices 在 2025 年的公开份额为 53.14%。
- technology 维度中，digital transducers 在 2025 年的公开份额为 40.25%。
主要参与者
- ICU Medical, Inc.
- Edwards Lifesciences Corporation
- B. Braun SE
- Smiths Group plc
- Merit Medical Systems, Inc.
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Rising Hypertension and Cardiovascular Disease Burden | +1.200% | Global, most acute in APAC and lower-middle-income countries | Long term (≥ 4 years) |
| ICU Expansion and Greater Invasive Hemodynamic Monitoring | +1.000% | North America, APAC, Europe | Medium term (2-4 years) |
| Shift from Reusable to Disposable Single-Patient-Use Transducers | +0.800% | Global, led by North America and Europe | Medium term (2-4 years) |
| Growth of Remote and Continuous Monitoring Use Cases | +0.600% | North America, APAC | Medium term (2-4 years) |
| Infection Prevention Priorities in Acute Care Settings | +0.500% | Global, with early gains in North America | Short term (≤ 2 years) |
| Adoption of Smart, Wireless, and Digital Transducer Systems | +0.700% | Global, with APAC adoption accelerating | Long term (≥ 4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| High Procurement Cost of Advanced Transducers | -0.600% | Global, most pronounced in LMIC and cost-constrained health systems | Medium term (2-4 years) |
| Substitution Risk from Non-Invasive Continuous Blood Pressure Monitoring | -0.400% | North America, Europe | Long term (≥ 4 years) |
| Reimbursement Pressure and GPO-Driven Price Compression | -0.300% | North America | Medium term (2-4 years) |
| Calibration, Compatibility, and Clinical Workflow Friction | -0.200% | Global | Short term (≤ 2 years) |
报告关注的关键问题
How large is the blood pressure transducers market?
The blood pressure transducers market is projected to grow from USD 1.81 billion in 2025 to USD 1.90 billion in 2026 to reach USD 2.56 billion, at a 6.12% CAGR through 2031.
Which product type is growing fastest?
Disposable blood pressure transducers are projected to grow at a 6.53% CAGR through 2031 as hospitals seek simpler setups and reduced reprocessing requirements.
Why do hospitals still use invasive monitoring?
Invasive blood pressure monitoring held 52.37% in 2025 because arterial-line measurement remains important for critically ill and unstable patients.
Which region will grow fastest through 2031?
Asia-Pacific is forecasted to grow at an 8.16% CAGR, supported by healthcare investment, critical care expansion, and hypertension-related demand.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence